NCT05844332 2025-12-22
LUTATHERA Injection General Use Result Survey
Novartis
Completed
Clinical Trials
4 trialsNCT04946305 2024-08-09
A Post Marketing Surveillance on Lutathera® in Patients With Somatostatin Receptor Positive Gastroenteropancreatic Neuroendocrine Tumor in Korea
Novartis
Completed
NCT05816720 2023-04-18
Retrospective Analysis of Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®)
Novartis
Completed
NCT01578239 2022-04-04
NETTER-1
Advanced Accelerator Applications
Phase 3 Completed